Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis.
about
APLAR rheumatoid arthritis treatment recommendations.Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus.Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan.RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report.Drug survival and the associated predictors in South Korean patients with rheumatoid arthritis receiving tacrolimus.Tacrolimus-induced hypertrophic cardiomyopathy in a patient with dermatomyositis.Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.
P2860
Q35762912-9B992B30-0DC6-4502-8D38-4403D8BFF6C5Q35782786-AD29A549-7E6D-40A7-A249-728AA0D304B7Q36327800-7CA4D1F5-2AA2-47D7-8B7D-366D5F8AD47DQ47718754-36F9C427-433A-469F-8F9E-F63BD388DBBCQ48615436-65463272-EF74-498E-96A7-7BCFED4A4DEBQ49370571-F4E48FFC-545E-4BAD-B0E0-8CCBAC4EC70EQ49607446-CB460126-1DB2-486A-BDDC-3B8C28C9CCEBQ50445051-2FC550BC-F9CC-4849-9B09-9757C47DFC50
P2860
Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Post-marketing surveillance of ...... nts with rheumatoid arthritis.
@en
Post-marketing surveillance of ...... nts with rheumatoid arthritis.
@nl
type
label
Post-marketing surveillance of ...... nts with rheumatoid arthritis.
@en
Post-marketing surveillance of ...... nts with rheumatoid arthritis.
@nl
prefLabel
Post-marketing surveillance of ...... nts with rheumatoid arthritis.
@en
Post-marketing surveillance of ...... nts with rheumatoid arthritis.
@nl
P2093
P2860
P1433
P1476
Post-marketing surveillance of ...... nts with rheumatoid arthritis.
@en
P2093
Kazuhiko Yamamoto
Kota Ishida
Masayoshi Harigai
Nobuyuki Miyasaka
Shinichi Kawai
P2860
P356
10.3109/14397595.2013.854074
P577
2014-01-01T00:00:00Z